IMODIUM PRO 1 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

imodium pro 1 mg tabletti

mcneil, a division of janssen- cilag oy - loperamidi oxidum monohydricum - tabletti - 1 mg - loperamidioksidi

IMODIUM PLUS 2 mg / 125 mg purutabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

imodium plus 2 mg / 125 mg purutabletti

mcneil, a division of janssen- cilag oy - simeticonum,loperamidi hydrochloridum - purutabletti - 2 mg / 125 mg - loperamidi, yhdistelmävalmisteet

LOPERUMA 2 mg / 125 mg purutabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

loperuma 2 mg / 125 mg purutabletti

disphar international b.v. - simeticonum,loperamidi hydrochloridum - purutabletti - 2 mg / 125 mg - loperamidi, yhdistelmävalmisteet

LOPEDIUM COMP 2 mg / 125 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

lopedium comp 2 mg / 125 mg tabletti

sandoz a/s sandoz a/s - simeticonum,loperamidi hydrochloridum - tabletti - 2 mg / 125 mg - loperamidi, yhdistelmävalmisteet

Zokinvy Euroopan unioni - suomi - EMA (European Medicines Agency)

zokinvy

eigerbio europe limited - lonafarnib - progeria; laminopathies - muut ruuansulatuselimistön sairauksien ja aineenvaihduntasairauksien lääkkeet, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.

Verzenios Euroopan unioni - suomi - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - rintojen kasvaimet - antineoplastiset aineet - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Truberzi Euroopan unioni - suomi - EMA (European Medicines Agency)

truberzi

allergan pharmaceuticals international limited - eluxadoline - irritable bowel syndrome; diarrhea - ripulilääkkeet, suoliston antiinflammatory / antiinfective agents - truberzi on tarkoitettu aikuisille ärtyvän suolen oireyhtymän ja ripulin hoitoon (ibs d).

Onivyde pegylated liposomal (previously known as Onivyde) Euroopan unioni - suomi - EMA (European Medicines Agency)

onivyde pegylated liposomal (previously known as onivyde)

les laboratoires servier - irinotecan anhydrous free-base - haimasyöpä - antineoplastiset aineet - hoito metastasoituneen haiman adenokarsinooman on, yhdessä 5 fluorourasiilin (5-fu) ja leucovorin (lv), aikuisilla, jotka ovat edenneet jälkeen gemsitabiini perustuu hoidon.

Agiocur rakeet Suomi - suomi - Fimea (Suomen lääkevirasto)

agiocur rakeet

viatris oy - ispaghula husk, plantago ovata seeds - rakeet - ispaghula

Dolmed 5 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

dolmed 5 mg tabletti

orifarm healthcare a/s - methadone hydrochloride - tabletti - 5 mg - metadoni